Cellexcel

Cellexcel is hugely proud to be a finalist in the KPMG Tech Innovator awards tonight. Best wishes to the participating Cellexcel team and also to all the applicants through the whole competition - our combined Innovation is the winner. #sustainability #biomaterials

Ten scale-up businesses from across the East of England have been shortlisted from nearly 400 applications to pitch their businesses to a panel of industry experts in the search for the UK’s next big tech disruptor. https://lnkd.in/eGV_jn5w KPMG’s annual competition, which showcases tech innovators from eight regions across the UK, has been running since 2013 and uncovered outstanding tech from businesses including what3words, VividQ, Mimicrete and HiiROC. The businesses from across the East of England region will pitch against each other to find one innovator who will represent the region at the UK finals. The local representation comprises bit.bio, Virilitas Labs, Developing Experts, VOLTQUANT, Paragraf®, Graphene Trace, ED Hub Ltd, DeepMirror, Cellexcel and Ediform. The winners of each regional stage go on to the national final to be held in London in July. The overall winner will represent the UK at the global final, which takes place alongside Web Summit later in the year where a panel of global judges will crown the 2024 KPMG Private Enterprise Global Tech Innovator. Salvatore Di Maggio LLM, who leads KPMG’s Emerging Giants practice locally said: “We had a high level of entries this year and our final 10 shortlisted businesses represent the best of the tech talent from our region. Our tech ecosystem continues to grow, and this competition is a great way to shine a spotlight on some of the amazing teams and exciting innovation that are being developed and nurtured here. “The judges are looking forward to hearing the pitches and meeting the founders who have taken this opportunity to move their businesses to the next level and I really hope the East of England is home to this years’ UK winner!” Joe Faulkner, Senior Partner for KPMG UK’s East Anglian practice and one of the judges, added: “Our winner needs to be able to tell the story of their business in a passionate way, but most importantly, they need to demonstrate how their technology is solving a problem and has the potential to grow into a successful business.”

The #21toWatch Top21.2024 Companies have been announced. A massive well done to BeyondMath is using #AI to solve the complex simulation of physics in engineering design orders of magnitude faster, providing reductions in time, cost and environmental impact when taking designs to production (Alan Patterson Darren Garvey Rob Kirk) Early, accurate detection. It is Cambridge Vision Technology’s mission to make the timely and accurate detection of Alzheimer's Disease available to everyone (Meredith Bird Andrew Kadis)   Cellexcel provides the key to unlock the use of biomaterials and radically change industry's carbon footprint. It does this through molecular modification of biomaterials to enhance their essential performance properties (Steven C.) ExpressionEdits’ proprietary intronization platform recodes transgenes to better resemble natural genes, leading to significant improvement in protein production – a key challenge for recombinant proteins and DNA medicines (Kärt Tomberg Rebecca Godfrey PhD) Kuano combines state-of-the-art simulation and AI to add quantum detail to structure-based drug discovery, helping to enable the design of next generation medicines (Vid Stojevic) Remedium are developing a new carbon capture technology, carbon capture battery, that captures CO2 from cement/steel plants and monetizes the variation in electricity price to make carbon capture profitable (Mohammad Saghafifar) Vector Bioscience Cambridge is a machine-learning enabled, drug delivery platform focused on oncology, facilitating novel treatments that are currently undruggable. We increase high local concentrations, minimise side effects, and allow room temperature storage of sensible cargoes (Lluna Gallego David Fairen-Jimenez) Appleyard Lees IP LLP Crayfish.io Marks & Clerk Penningtons Manches Cooper LLP EBCam Employee Benefits & Independent Financial Advisers Norwich Research Park University of East Anglia

The #21toWatch Top21.2024 Companies have been announced. A massive well done to BeyondMath is using #AI to solve the complex simulation of physics in engineering design orders of magnitude faster, providing reductions in time, cost and environmental impact when taking designs to production (Alan Patterson Darren Garvey Rob Kirk) Early, accurate detection. It is Cambridge Vision Technology’s mission to make the timely and accurate detection of Alzheimer's Disease available to everyone (Meredith Bird Andrew Kadis)   Cellexcel provides the key to unlock the use of biomaterials and radically change industry's carbon footprint. It does this through molecular modification of biomaterials to enhance their essential performance properties (Steven C.) ExpressionEdits’ proprietary intronization platform recodes transgenes to better resemble natural genes, leading to significant improvement in protein production – a key challenge for recombinant proteins and DNA medicines (Kärt Tomberg Rebecca Godfrey PhD) Kuano combines state-of-the-art simulation and AI to add quantum detail to structure-based drug discovery, helping to enable the design of next generation medicines (Vid Stojevic) Remedium are developing a new carbon capture technology, carbon capture battery, that captures CO2 from cement/steel plants and monetizes the variation in electricity price to make carbon capture profitable (Mohammad Saghafifar) Vector Bioscience Cambridge is a machine-learning enabled, drug delivery platform focused on oncology, facilitating novel treatments that are currently undruggable. We increase high local concentrations, minimise side effects, and allow room temperature storage of sensible cargoes (Lluna Gallego David Fairen-Jimenez) Appleyard Lees IP LLP Crayfish.io Marks & Clerk Penningtons Manches Cooper LLP EBCam Employee Benefits & Independent Financial Advisers Norwich Research Park University of East Anglia